Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Ptosis, Eyelid

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Ptosis, Eyelid in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woods-Kettelberger, AT1
Smith, CP1
Corbett, R1
Szewczak, MR1
Roehr, JE1
Bores, GM1
Klein, JT1
Kongsamut, S1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Ptosis, Eyelid

ArticleYear
Besipirdine (HP 749) reduces schedule-induced polydipsia in rats.
    Brain research bulletin, 1996, Volume: 41, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biogenic Amines; Blepharoptosis; Conditioning, Oper

1996